Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1

4(57.1%)

N/A

1(14.3%)

Phase 3

1(14.3%)

Phase 2

1(14.3%)

7Total

Phase 1(4)

N/A(1)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05029401Phase 1Completed

A Study of Oral Ibogaine in Opioid Withdrawal

Role: collaborator

NCT04566653Completed

Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia

Role: collaborator

NCT04560816Phase 1Completed

A Study of the Cardiac Effects of ALXN1840 in Healthy Adults

Role: collaborator

NCT03029247Phase 2Completed

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

Role: collaborator

NCT03680105Phase 1Completed

A Safety and Tolerability Study of RJX Drug Product in Healthy Participants

Role: collaborator

NCT04168723Phase 1Unknown

TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects

Role: collaborator

NCT03202004Phase 3Withdrawn

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Role: collaborator

NCT00314886Not ApplicableUnknown

Effect of Butyrogenic Fibers in IBS Patients

Role: collaborator

All 8 trials loaded